A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis

Journal of Neuroimmunology

Volumn 226, Issue 1-2, 2010, Pages 192-193

  Ligocki, A J ^a   Lovato, L ^b   Xiang, D ^a   Guidry, P ^a   Scheuermann, R H ^a   Willis, S N ^b   Almendinger, S ^b   Racke, M K ^c   Frohman, E M ^d   Hafler, D A ^e   O'Connor, K C ^b   Monson, N L ^a,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody gene rearrangement; B lymphocytes; CNS tissue; Multiple sclerosis; Somatic hypermutation

Indexed keywords

B LYMPHOCYTE RECEPTOR; ANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; AGED; ANTIBODY GENE SIGNATURE; ARTICLE; AUTOPSY; B LYMPHOCYTE; BRAIN TISSUE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MALE; MOLECULAR GENETICS; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; CENTRAL NERVOUS SYSTEM; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ANTIBODIES; B-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTORS, ANTIGEN, B-CELL;

EID: 77956339538     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.06.016     Document Type: Article

References (14)

1. Antel J., Bar-Or A. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment. J. Neuroimmunol. 2006, 180:3-8.
2. Cameron E.M., Spencer S., Lazarini J., Harp C.T., Ward E.S., Burgoon M., Owens G.P., Racke M.K., Bennett J.L., Frohman E.M., Monson N.L. Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. J. Neuroimmunol. 2009, 213:123-130.
3. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., Bar-Or A., Panzara M., Sarkar N., Agarwal S., Langer-Gould A., Smith C.H. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 2008, 358:676-688.
4. Lassmann H., Bruck W., Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol. Med. 2001, 7:115-121.
5. Lassmann H., Bruck W., Lucchinetti C.F. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007, 17:210-218.
6. Lefranc M.P. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 2001, 29:207-209.
7. McFarland H.F. The B cell-old player, new position on the team. N. Engl. J. Med. 2008, 358:664-665.
8. Meinl E., Krumbholz M., Hohlfeld R. B lineage cells in the inflammatory central nervous system environment: migratoin, maintenance, local antibody production, and therapeutic modulation. Ann. Neurol. 2006, 59:880-892.
9. Owens G.P., Bennett J.L., Gilden D.H., Burgoon M.P. The B cell response in multiple sclerosis. Neurol. Res. 2006, 28:236-244.
10. Pittock S.J., Lucchinetti C.F. The pathology of MS: new insights and potential clinical applications. Neurologist 2007, 13:45-56.
11. Ransohoff R.M., Kivisakk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 2003, 3:569-581.
12. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 2004, 14:164-174.
13. Uccelli A., Aloisi F., Pistoia V. Unveiling the enigma of the CNS as a B-cell fostering environment. Trends Immunol. 2005, 26:254-259.
14. Willis S.N., Mallozzi S.S., Rodig S.J., Cronk K.M., McArdel S.L., Caron T., Pinkus G.S., Lovato L., Shampain K.L., Anderson D.E., Anderson R.C., Bruce J.N., O'Connor K.C. The microenvironment of germ cell tumors harbors a prominent antigen-driven humoral response. J. Immunol. 2009, 182:3310-3317.